A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16 + cervical intraepithelial neoplasia 2/3 (CIN2/3)-Reference-Cited by-同舟云学术

A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16 + cervical intraepithelial neoplasia 2/3 (CIN2/3)

Published:2016-02 Issue:2 Volume:140 Page:245-252
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Alvarez Ronald D.,Huh Warner K.,Bae Sejong,Lamb Lawrence S.,Conner Michael G.,Boyer Jean,Wang Chenguang,Hung Chien-Fu,Sauter Elizabeth,Paradis Mihaela,Adams Emily A.,Hester Shirley,Jackson Bradford E.,Wu T.C.^ORCID,Trimble Cornelia L.

Funder

Johns Hopkins/UAB Cervical Cancer

NCI NExT Program

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference32 articles.

1. Control of HPV infection and related cancer through vaccination. Recent results in cancer research;Tran;Fortschritte der Krebsforschung Progres dans les recherches sur le cancer,2014

2. HPV vaccines to prevent cervical cancer and genital warts: an update;Dochez;Vaccine,2014

3. Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels;Jemal;J. Natl. Cancer Inst.,2013

4. Loop electrosurgical excision procedure and the risk for preterm delivery;Heinonen;Obstet. Gynecol.,2013

5. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions;Vinokurova;Cancer Res.,2008

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review;Cancers;2024-02-05

2. Immunotherapy that leverages HPV-specific immune responses for precancer lesions of cervical cancer;Taiwanese Journal of Obstetrics and Gynecology;2024-01

3. Recent Updates on the Management of Human Papillomavirus-related Cancers;Current Cancer Therapy Reviews;2023-11

4. Human Papillomavirus Vaccines;Clinical Obstetrics & Gynecology;2023-07-25

5. The landscape of T cell antigens for cancer immunotherapy;Nature Cancer;2023-07-06